Page last updated: 2024-11-01
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Anemia, Sickle Cell
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Anemia, Sickle Cell in 1 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Anemia, Sickle Cell: A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ferguson, GD | 1 |
Jensen-Pergakes, K | 1 |
Wilkey, C | 1 |
Jhaveri, U | 1 |
Richard, N | 1 |
Verhelle, D | 1 |
De Parseval, LM | 1 |
Corral, LG | 1 |
Xie, W | 1 |
Morris, CL | 1 |
Brady, H | 1 |
Chan, K | 1 |
Other Studies
1 other study available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Anemia, Sickle Cell
Article | Year |
---|---|
Immunomodulatory drug CC-4047 is a cell-type and stimulus-selective transcriptional inhibitor of cyclooxygenase 2.
Topics: Anemia, Sickle Cell; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cyclooxygenase 2; C | 2007 |